We are proud to announce that we have teamed up with Cambridge-based biotech company TwistDx. Their technology offers a highly versatile and alternative solution to traditional polymerase chain reactions (PCR). The result is a faster, more portable detection of nucleic acid detection assays.

Together, TwistDx’s technological innovation paired with UBC’s ability to pinpoint valuable market areas, develop and implement strategic growth plans, refine processes, and grow brand awareness creates a “win-win” solution that benefits the biotech industry.